Akoya Biosciences Stock Price Prediction
| AKYA Stock | USD 3.13 0.08 2.49% |
Oversold Vs Overbought
47
Oversold | Overbought |
EPS Estimate Next Quarter (0.19) | EPS Estimate Current Year (1.05) | EPS Estimate Next Year (0.59) | Wall Street Target Price 4.8 | EPS Estimate Current Quarter (0.27) |
Using Akoya Biosciences hype-based prediction, you can estimate the value of Akoya Biosciences from the perspective of Akoya Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Akoya Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Akoya because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Akoya Biosciences after-hype prediction price | USD 3.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Akoya |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akoya Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akoya Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Akoya Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Akoya Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Akoya Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Akoya Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Akoya Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Akoya Biosciences' historical news coverage. Akoya Biosciences' after-hype downside and upside margins for the prediction period are 0.17 and 8.14, respectively. We have considered Akoya Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Akoya Biosciences is relatively risky at this time. Analysis and calculation of next after-hype price of Akoya Biosciences is based on 3 months time horizon.
Akoya Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Akoya Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akoya Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Akoya Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.50 | 4.80 | 0.21 | 0.30 | 5 Events / Month | 9 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.13 | 3.34 | 6.71 |
|
Akoya Biosciences Hype Timeline
Akoya Biosciences is presently traded for 3.13. The entity has historical hype elasticity of 0.21, and average elasticity to hype of competition of -0.3. Akoya is anticipated to increase in value after the next headline, with the price projected to jump to 3.34 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 6.71%, whereas the daily expected return is presently at 0.5%. The volatility of related hype on Akoya Biosciences is about 806.72%, with the expected price after the next announcement by competition of 2.83. The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.47. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days. Check out Akoya Biosciences Basic Forecasting Models to cross-verify your projections.Akoya Biosciences Related Hype Analysis
Having access to credible news sources related to Akoya Biosciences' direct competition is more important than ever and may enhance your ability to predict Akoya Biosciences' future price movements. Getting to know how Akoya Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Akoya Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ATRC | AtriCure | 0.43 | 9 per month | 1.37 | 0.19 | 5.38 | (3.12) | 23.09 | |
| ATRI | ATRION | (0.10) | 7 per month | 0.00 | (0.16) | 0.94 | (1.35) | 6.29 | |
| ICUI | ICU Medical | (4.67) | 12 per month | 1.18 | 0.06 | 2.97 | (1.92) | 9.65 | |
| HAE | Haemonetics | 0.70 | 10 per month | 1.06 | 0.1 | 4.24 | (2.02) | 12.42 | |
| ANGO | AngioDynamics | (0.37) | 13 per month | 0.00 | (0.05) | 4.04 | (4.03) | 20.78 | |
| ATR | AptarGroup | (1.18) | 9 per month | 0.29 | 0.17 | 1.67 | (1.18) | 5.06 | |
| COO | The Cooper Companies, | (1.48) | 10 per month | 0.96 | 0.01 | 1.53 | (1.79) | 13.98 | |
| INFU | InfuSystems Holdings | 0.01 | 10 per month | 2.79 | 0.09 | 7.64 | (4.81) | 22.10 | |
| PDEX | Pro Dex | 0.21 | 11 per month | 3.44 | 0.28 | 9.99 | (5.17) | 26.61 | |
| LMAT | LeMaitre Vascular | (0.02) | 7 per month | 1.24 | 0.11 | 3.15 | (2.19) | 10.31 | |
| UTMD | Utah Medical Products | (0.63) | 9 per month | 0.78 | (0.10) | 1.50 | (1.35) | 6.99 | |
| MLSS | Milestone Scientific | (0.04) | 8 per month | 0.00 | (0.16) | 5.56 | (7.89) | 27.59 |
Akoya Biosciences Additional Predictive Modules
Most predictive techniques to examine Akoya price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Akoya using various technical indicators. When you analyze Akoya charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Akoya Biosciences Predictive Indicators
The successful prediction of Akoya Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Akoya Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Akoya Biosciences based on analysis of Akoya Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Akoya Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Akoya Biosciences's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.002254 | 0.002004 | Price To Sales Ratio | 2.24 | 2.13 |
Story Coverage note for Akoya Biosciences
The number of cover stories for Akoya Biosciences depends on current market conditions and Akoya Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Akoya Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Akoya Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Akoya Biosciences Short Properties
Akoya Biosciences' future price predictability will typically decrease when Akoya Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Akoya Biosciences often depends not only on the future outlook of the potential Akoya Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akoya Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.4 M | |
| Cash And Short Term Investments | 83.1 M |
Complementary Tools for Akoya Stock analysis
When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |